Nicotine free cigarettes is one of 209 small molecule programs targeting Nicotine Dependence. It is currently in Phase 3.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
73 competitors in Effectiveness
Kesimpta
Mounjaro
Actos
Botulinum Toxin a
Droxia
Nicotine free cigarettes
Temodar
Welireg
Haldol
Pneumococcal Conjugate Vaccine
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Clinical
Sources